Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001709961-17-000001
Filing Date
2017-06-21
Accepted
2017-06-21 14:26:35
Documents
1
Effectiveness Date
2017-06-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8295
  Complete submission text file 0001709961-17-000001.txt   9334
Mailing Address 101 LINDENWOOD DRIVE, SUITE 400 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 400 MALVERN PA 19355 484-318-2988
Onspira Therapeutics, Inc. (Filer) CIK: 0001709961 (see all company filings)

EIN.: 821159923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-289166 | Film No.: 17922664